Skip to Content Facebook Feature Image

ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus

Business

ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus
Business

Business

ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus

2026-02-10 16:01 Last Updated At:20:05

CORK, Ireland, Feb. 10, 2026 /PRNewswire/ -- ArrayPatch Ltd, a biotech company developing innovative microneedle-based therapeutics, today announced the first close of its €3 million seed funding round, to advance its lead program ITZ-DerMap™, a novel therapeutic designed for the treatment of onychomycosis (nail fungus).

€1.6 million of the round has now been secured, led by Lakeside Capital Ltd. Additional investors included Enterprise Ireland, The Boole Investment Syndicate and DeepIE Ventures. Sean Corkery, Director at Lakeside Capital Ltd, will join the ArrayPatch Board of Directors in conjunction with the investment. €0.3 million of previously issued convertible loan notes along with accrued interest also converted into equity in the company following the first close.

The new financing will enable ArrayPatch to accelerate the clinical development of ITZ-DerMap™, the first product emerging from its proprietary DerMap™ platform, towards clinical proof-of-concept. DerMapTM is a pain-free microneedle patch comprising microscopic needles which are uniquely polymer-free and made entirely from the drug being delivered. On application of the patch, the microneedles penetrate the outer layer of skin, dissolve and release medication to the target site.  

"With this first close of our seed round secured, we are well-positioned to advance ITZ-DerMap™ into clinical development and bring a transformational treatment option to patients suffering from nail fungus," said Dr. Waleed Faisal, Co-Founder and CEO of ArrayPatch.

"We are pleased to support ArrayPatch at this exciting early stage," said Sean Corkery, Director at Lakeside Capital. "The team's innovative approach to targeted drug delivery positions the company for a breakthrough clinical and commercial opportunity in multi-billion dollar global therapeutic markets."

ArrayPatch Ltd was the winner of the InterTradeIreland all-island Seedcorn Investor Readiness Competition 2025, winner of the 2023 IDEATE Ireland competition and Innovation of the Year at the 2022 Irish Pharma Awards.

About ArrayPatch Ltd

ArrayPatch is a biotech company based in Cork, Ireland, developing next-generation microneedle-based therapeutics. Its DerMap™ platform harnesses polymer-free dissolving microneedles to deliver therapeutic agents directly to target tissues in a painless and efficient manner. The company's lead program, ITZ-DerMap™, is designed to address the significant unmet medical need in onychomycosis (nail fungus), with additional applications under development for skin cancer, diabetes, weight loss and migraine. ArrayPatch was spun out from University College Cork and has secured significant non-dilutive funding and industry recognition to support its development strategy. For more information, please visit www.array-patch.com 

Contact:

Dr. Waleed Faisal
Founder, CEO
waleed-faisal@array-patch.com 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus

ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus

BEIJING, April 3, 2026 /PRNewswire/ -- In China, traditional festivals such as the Spring Festival and Mid-Autumn Festival are days to celebrate reunion.

While Chinese people return home for family gatherings during such holidays, some overseas Chinese and foreigners in China find it captivating to savor a cup of baijiu to experience the oriental essence.

Among their diverse choices, Fenjiu, a light-flavor Chinese baijiu, was one of the optimal choices that conquered the taste buds of many and gained more popularity abroad this February.

In Canada, a spring temple fair for overseas Chinese from north China's Shanxi Province where Fenjiu Group, the producer of Fenjiu, is situated, was thronged by visitors eager to taste Qinghua Fenjiu, Rose Fenjiu and other Fenjiu products with refreshing aroma, refined flavors and smooth texture.

In Australia, a celebration of the Year of the Horse in Chinatown of Melbourne presented the Fenjiu special Panama edition and 30-year-old Qinghua Fenjiu with upscale black and gold packaging to overseas Chinese there and captured their hearts.

Elsewhere in the Chinese food restaurants in Paris of France and streets of Madrid in Spain, Fenjiu products are always spotted on tables of overseas Chinese during the holidays.

In Greece and the UAE, similar venues or events akin to the above-mentioned ones welcomed more foreigners to experience the traditional Chinese holiday while enjoying a cup of the distinguished Chinese baijiu.

In Chinese cities, an increasing number of foreigners had opted in February for a China travel to feel the warmth and charm of the Spring Festival when celebrating the festival in China is evolving into a new global fashion.

Already collected in Kremlin Museum in Moscow, Qinghua Fenjiu, a premium Fenjiu product, is showing how foreign friends have understood the oriental brewing wisdom and cultural inclusiveness.

Original link: https://en.imsilkroad.com/p/350006.html

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Xinhua Silk Road: Savor a cup of Fenjiu to cheer for reunion

Xinhua Silk Road: Savor a cup of Fenjiu to cheer for reunion

Recommended Articles